Professor Sanjoy Paul is an internationally recognised clinical trialist, biostatistician and a real-world electronic medical record (EMR) data scientist with long-standing experience in design and conduct of clinical trials and pharmaco-epidemiological studies in the fields of metabolic diseases. Prof. Paul’s current role is Chair Professor of Clinical Biostatistics, Epidemiology & Health Services Research, University of Melbourne, and Director of the Melbourne EpiCentre, a collaborative centre of research excellence. Prior to moving to Australia, Prof. Paul created the Statistics & Modelling Group of the University of Oxford Centre for Diabetes, Endocrinology and Metabolism in the UK. He is actively involved in the strategic aspects of Australian federal government and Victorian state government’s initiatives to develop EMRs in Australia. He also acts as an expert advisor to Therapeutic Goods Administration of Australia (TGA) and programmes led by his international academic and industry collaborators. In addition to attracting significant competitive research grants (~$19 million since 2010). Currently Prof. Paul is running 8 early and late phase multicenter/multinational clinical trials, and leading pharmaco-epidemiological studies in the fields of auto-immune and metabolic diseases combining clinical trial and large EMRs. He has designed, written study protocols and statistical analysis plans for over 100 funded clinical studies.
Prof. Paul has published in highly acclaimed research journals that include the New England Journal of Medicine (NEJM), Diabetes, Diabetes Care, Diabetologia, Science Translational Medicine, Clinical Infectious Diseases and Diabetes Obesity & Metabolism, with more than 7200 citations over last 5 years and M-Index of 1.9, having commenced his research career in 2004. Selected publications of Prof. Paul can be tracked in Google Scholar.